TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro
2011

TRAIL Receptor Signaling and Chemosensitivity

publication Evidence: moderate

Author Information

Author(s): Menke Christina, Goncharov Tatiana, Qamar Lubna, Korch Christopher, Ford Heide L., Behbakht Kian, Thorburn Andrew

Primary Institution: University of Colorado School of Medicine

Hypothesis

Does TRAIL receptor signaling affect chemosensitivity in vivo compared to in vitro?

Conclusion

TRAIL receptor signaling influences tumor chemosensitivity in vivo but not in vitro.

Supporting Evidence

  • Inhibition of TRAIL receptors did not affect in vitro tumor cell killing.
  • Selective inhibition of TRAIL receptor signaling reduced tumor regression in vivo.
  • TRAIL resistance mechanisms in tumors may lead to reduced effectiveness of chemotherapy.

Takeaway

This study found that how cancer cells respond to treatments can be different in the lab compared to in real living organisms.

Methodology

The study used isogenic BJAB human lymphoma cells to assess the effects of TRAIL receptor signaling on chemosensitivity.

Limitations

The study primarily used cell lines and may not fully represent human tumor behavior.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014527

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication